Stress associated gene expression in blood cells is related to outcome in radiotherapy treated head and neck cancer patients

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Bøhn, Siv K ^a   Russnes, Kjell M ^b   Sakhi, Amrit K ^a   Thoresen, Magne ^a   Holden, Marit ^c   Moskaug, JanØ ^a   Myhrstad, Mari C ^a   Olstad, Ole K ^d   Smeland, Sigbjørn ^a,b   Blomhoff, Rune ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c NORWEGIAN COMPUTING CENTER   (Norway)

^d ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Antioxidants; Cancer; GSEA; HNSCC; Microarray; Radiotherapy

Indexed keywords

ANTIOXIDANT;

ADULT; ARTICLE; BLOOD CELL; BLOOD CHEMISTRY; BLOOD LEVEL; CANCER GENETICS; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESISTANCE; CELL DAMAGE; CELL STRESS; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE INDUCTION; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; RADIOSENSITIVITY; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; ANALYSIS OF VARIANCE; BAYES THEOREM; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84870695246     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-426     Document Type: Article

References (39)

1. Barcellos-Hoff MH, Park C, Wright EG. Radiation and the microenvironment - tumorigenesis and therapy. Nat Rev Cancer 2005, 5:867-875. 10.1038/nrc1735, 16327765.
2. Sturgis EM, Wei Q, Spitz MR. Descriptive epidemiology and risk factors for head and neck cancer. Semin Oncol 2004, 31:726-733. 10.1053/j.seminoncol.2004.09.013, 15599850.
3. Pelucchi C, Gallus S, Garavello W, Bosetti C, La VC. Alcohol and tobacco use, and cancer risk for upper aerodigestive tract and liver. Eur J Cancer Prev 2008, 17:340-344. 10.1097/CEJ.0b013e3282f75e91, 18562959.
4. World Cancer Research Fund / American Institute for Cancer Research Food, Nutrition, Physical Activity, and the Prevention of Cancer 2007, Washington DC: a Global Perspective, World Cancer Research Fund / American Institute for Cancer Research.
5. Bohn SK, Smeland S, Sakhi AK, Thoresen M, Russnes KM, Tausjo J, Svilaas A, Svilaas T, Blomhoff R. Post-radiotherapy plasma total glutathione is associated to outcome in patients with head and neck squamous cell carcinoma. Cancer Lett 2006, 238:240-247. 10.1016/j.canlet.2005.07.027, 16157445.
6. Sakhi AK, Bohn SK, Smeland S, Thoresen M, Smedshaug GB, Tausjo J, Svilaas A, Karlsen A, Russnes KM, Svilaas T, et al. Postradiotherapy plasma lutein, alpha-carotene, and beta-carotene are positively associated with survival in patients with head and neck squamous cell carcinoma. Nutr Cancer 2010, 62:322-328. 10.1080/01635580903441188, 20358469.
7. Sakhi AK, Russnes KM, Thoresen M, Bastani NE, Karlsen A, Smeland S, Blomhoff R. Pre-radiotherapy plasma carotenoids and markers of oxidative stress are associated with survival in head and neck squamous cell carcinoma patients: a prospective study. BMC Cancer 2009, 9:458. 10.1186/1471-2407-9-458, 2813240, 20025747.
8. de Nadal E, Ammerer G, Posas F. Controlling gene expression in response to stress. Nat Rev Genet 2011, 12:833-845.
9. Ogawa K, Murayama S, Mori M. Predicting the tumor response to radiotherapy using microarray analysis (Review). Oncol Rep 2007, 18:1243-1248.
10. Khodarev NN, Beckett M, Labay E, Darga T, Roizman B, Weichselbaum RR. STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 2004, 101:1714-1719. 10.1073/pnas.0308102100, 341831, 14755057.
11. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, Stoeckert C, Aach J, Ansorge W, Ball CA, Causton HC, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001, 29:365-371. 10.1038/ng1201-365, 11726920.
12. Ishwaran H, Rao JS, Kogalur UB. BAMarraytrade mark: Java software for Bayesian analysis of variance for microarray data. BMC Bioinforma 2006, 7:59.
13. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
14. Bohn SK, Myhrstad MC, Thoresen M, Holden M, Karlsen A, Tunheim SH, Erlund I, Svendsen M, Seljeflot I, Moskaug JO, et al. Blood cell gene expression associated with cellular stress defense is modulated by antioxidant-rich food in a randomised controlled clinical trial of male smokers. BMC Med 2010, 8:54. 10.1186/1741-7015-8-54, 2955589, 20846424.
15. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998, 273:28545-28548. 10.1074/jbc.273.44.28545, 9786841.
16. Pandit A, Vadnal J, Houston S, Freeman E, McDonough J. Impaired regulation of electron transport chain subunit genes by nuclear respiratory factor 2 in multiple sclerosis. J Neurol Sci 2009, 279:14-20. 10.1016/j.jns.2009.01.009, 19187944.
17. Matsumura S, Demaria S. Up-regulation of the pro-inflammatory chemokine CXCL16 is a common response of tumor cells to ionizing radiation. Radiat Res 2010, 173:418-425. 10.1667/RR1860.1, 2857712, 20334513.
18. Hong JH, Chiang CS, Sun JR, Withers HR, McBride WH. Induction of c-fos and junB mRNA following in vivo brain irradiation. Brain Res Mol Brain Res 1997, 48:223-228.
19. Sugimoto K, Maekawa Y, Kitamura A, Nishida J, Koyanagi A, Yagita H, Kojima H, Chiba S, Shimada M, Yasutomo K. Notch2 signaling is required for potent antitumor immunity in vivo. J Immunol 2010, 184:4673-4678. 10.4049/jimmunol.0903661, 20351182.
20. Bandres E, Malumbres R, Cubedo E, Honorato B, Zarate R, Labarga A, Gabisu U, Sola JJ, Garcia-Foncillas J. A gene signature of 8 genes could identify the risk of recurrence and progression in Dukes' B colon cancer patients. Oncol Rep 2007, 17:1089-1094.
21. Zhao J, Ni H, Ma Y, Dong L, Dai J, Zhao F, Yan X, Lu B, Xu H, Guo Y. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression. Hum Pathol 2007, 38:293-298. 10.1016/j.humpath.2006.08.005, 17097132.
22. Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjanen S, Syrjanen K, Collan Y, Pyrhonen S. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients. Cancer Invest 2010, 28:38-43. 10.3109/07357900802672761, 20001295.
23. Qu Y, Zhang H, Zhao S, Hong J, Tang C. The effect on radioresistance of manganese superoxide dismutase in nasopharyngeal carcinoma. Oncol Rep 2010, 23:1005-1011.
24. Fountzilas G, Kalogera-Fountzila A, Lambaki S, Wirtz RM, Nikolaou A, Karayannopoulou G, Bobos M, Kotoula V, Murray S, Lambropoulos A, et al. MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer. J Oncol 2009, 2009:305908. 2801452, 20066159.
25. Talbert PB, Henikoff S. Histone variants-ancient wrap artists of the epigenome. Nat Rev Mol Cell Biol 2010, 11:264-275.
26. Jeong WS, Jun M, Kong AN. Nrf2: a potential molecular target for cancer chemoprevention by natural compounds. Antioxid Redox Signal 2006, 8:99-106. 10.1089/ars.2006.8.99, 16487042.
27. Hannani D, Sistigu A, Kepp O, Galluzzi L, Kroemer G, Zitvogel L. Prerequisites for the antitumor vaccine-like effect of chemotherapy and radiotherapy. Cancer J 2011, 17:351-358. 10.1097/PPO.0b013e3182325d4d, 21952286.
28. Lisanti MP, Martinez-Outschoorn UE, Pavlides S, Whitaker-Menezes D, Pestell RG, Howell A, Sotgia F. Accelerated aging in the tumor microenvironment: connecting aging, inflammation and cancer metabolism with personalized medicine. Cell Cycle 2011, 10:2059-2063. 3154359, 21654190.
29. Yin X, Zhang H, Lundgren K, Wilson L, Burrows F, Shores CG. BIIB021, a novel Hsp90 inhibitor, sensitizes head and neck squamous cell carcinoma to radiotherapy. Int J Cancer 2010, 126:1216-1225.
30. Ballatori N, Krance SM, Notenboom S, Shi S, Tieu K, Hammond CL. Glutathione dysregulation and the etiology and progression of human diseases. Biol Chem 2009, 390:191-214. 2756154, 19166318.
31. Hercbergs A, Brok-Simoni F, Holtzman F, Bar-Am J, Leith JT, Brenner HJ. Erythrocyte glutathione and tumour response to chemotherapy. Lancet 1992, 339:1074-1076. 10.1016/0140-6736(92)90664-O, 1349103.
32. Anasagasti MJ, Martin JJ, Mendoza L, Obrador E, Estrela JM, McCuskey RS, Vidal-Vanaclocha F. Glutathione protects metastatic melanoma cells against oxidative stress in the murine hepatic microvasculature. Hepatology 1998, 27:1249-1256. 10.1002/hep.510270510, 9581678.
33. Semenza GL. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001, 7:345-350. 10.1016/S1471-4914(01)02090-1, 11516994.
34. Guo G, Yan-Sanders Y, Lyn-Cook BD, Wang T, Tamae D, Ogi J, Khaletskiy A, Li Z, Weydert C, Longmate JA, et al. Manganese superoxide dismutase-mediated gene expression in radiation-induced adaptive responses. Mol Cell Biol 2003, 23:2362-2378. 10.1128/MCB.23.7.2362-2378.2003, 150726, 12640121.
35. Shimizu T, Iwanaga M, Yasunaga A, Urata Y, Goto S, Shibata S, Kondo T. Protective role of glutathione synthesis on radiation-induced DNA damage in rabbit brain. Cell Mol Neurobiol 1998, 18:299-310. 10.1023/A:1022525214871, 9590560.
36. Kim SG, Nam SY, Kim CW, Kim JH, Cho CK, Yoo SY. Enhancement of radiation-inducible hepatic glutathione-S-transferases Ya, Yb1, Yb2, Yc1, and Yc2 gene expression by oltipraz: possible role in radioprotection. Mol Pharmacol 1997, 51:225-233.
37. Summers RW, Maves BV, Reeves RD, Arjes LJ, Oberley LW. Irradiation increases superoxide dismutase in rat intestinal smooth muscle. Free Radic Biol Med 1989, 6:261-270. 10.1016/0891-5849(89)90053-1, 2744576.
38. Oberley LW, St Clair DK, Autor AP, Oberley TD. Increase in manganese superoxide dismutase activity in the mouse heart after X-irradiation. Arch Biochem Biophys 1987, 254:69-80. 10.1016/0003-9861(87)90082-8, 3579307.
39. Strongin A, Yovino S, Taylor R, Wolf J, Cullen K, Zimrin A, Strome S, Regine W, Suntharalingam M. Primary Tumor Volume Is an Important Predictor of Clinical Outcomes Among Patients With Locally Advanced Squamous Cell Cancer of the Head and Neck Treated With Definitive Chemoradiotherapy. Int J Radiat Oncol Biol Phys 2012, 82:1823-1830. 10.1016/j.ijrobp.2010.10.053, 21549516.